Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?

E-ISSN： 1873-4286|16|5|488-501

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.5, 2010-02, pp. : 488-501

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity

Current Neuropharmacology, Vol. 15, Iss. 8, 2017-11 ,pp. : 1192-1207

Bentham Science Publishers

Access to resources Recommend Favorite

Biased Agonism at the Parathyroid Hormone Receptor: A Demonstration of Functional Selectivity in Bone Metabolism

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 9, 2012-08 ,pp. : 856-865

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological basis for functional selectivity of partial muscarinic receptor agonists

By Heldman E. Barg J. Fisher A. Levy R. Pittel Z. Zimlichman R. Kushnir M. Vogel Z.

European Journal of Pharmacology, Vol. 297, Iss. 3, 1996-02 ,pp. : 283-291

Elsevier

Access to resources Recommend Favorite

Antipsychotic Medication: The Potential Role of 5-HT1A Receptor Agonism

Current Pharmaceutical Design, Vol. 16, Iss. 5, 2010-02 ,pp. : 516-521

Bentham Science Publishers

Access to resources Recommend Favorite

Functional partial agonism at cloned human muscarinic acetylcholine receptors

By Brauner-Osborne H. Ebert B. Brann M.R. Falch E. Krogsgaard-Larsen P.

European Journal of Pharmacology, Vol. 313, Iss. 1, 1996-10 ,pp. : 145-150

Elsevier

Access to resources Recommend Favorite